LYONS GARY A bought NBIX
May 14, 2024 · Form 4 insider transaction
LYONS GARY A bought 12,500 shares of Neurocrine Biosciences, Inc. at $42.76 per share, a transaction worth $534.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,500
Price
$42.76
Total value
$534.5K
InsiderLYONS GARY A
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 14, 2024
Filing dateMay 16, 2024
Shares owned after129,447
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects a decrease of 76,750 shares from the amount previously reported as beneficially owned, which was recently discovered to be overstated due to an administrative oversight.; 110,964 of the reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power.